Skip to content

Welcome to Discover Pharma! Today is : October 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Artificial intelligence

  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Medical devices,Opinion & Events

    Magentiq Eye secures Series A funding to advance AI-powered colonoscopy solutions

    Investment led by aMoon will support US and EU commercialisation [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Biostate AI expands RNA-based precision medicine with new partnerships across China, India and the US

    Global collaborations boost dataset powering AI diagnostics for cancer, cardiovascular [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    AI-powered initiative in Louisiana aims to accelerate ALS drug discovery

    A new AI-led collaboration is being launched to advance drug [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Pistoia Alliance expands into pharmacovigilance space with launch of two new initiatives

    Collaboration efforts aim to reduce manual burden of adverse event [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Therapeutic Areas

    Caris CMO on AI, equity, and the future of multi-omic oncology

    The former ASCO president shares his insights on breast cancer [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    PharmaForceIQ reports strong growth as demand for optichannel strategies rises

    PharmaForceIQ, an independent provider of precision customer engagement technologies for [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    FDA launches AI tool Elsa to boost internal efficiency and accelerate reviews

    The US Food and Drug Administration (FDA) has unveiled Elsa, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Yseop on FDA’s AI push: Why structured, explainable content is the future of regulatory submissions

    As the FDA accelerates its use of generative AI in [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    FDA fast-tracks generative AI rollout following successful scientific review pilot

    The US Food and Drug Administration (FDA) has announced plans [...]

    May 5, 2026
  • Digital & Data

    Indegene outlines critical GenAI lessons and strategies for the future of life sciences

    May 5, 2026
Previous456Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Ariadne Bio launches with Parkinson’s apathy drug candidate
    Categories: Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • MaaT Pharma to advance Phase 3 trial after EMA rejects MaaT013 application
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top